BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6445926)

  • 1. Control of serum C3 levels by beta 1H and C3b inactivator.
    Wyatt RJ; Forristal J; Davis CA; Coleman TH; West CD
    J Lab Clin Med; 1980 Jun; 95(6):905-17. PubMed ID: 6445926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K; Ward D; Ruddy S
    Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial H (beta 1H) deficiency and glomerulonephritis in two families.
    Wyatt RJ; Julian BA; Weinstein A; Rothfield NF; McLean RH
    J Clin Immunol; 1982 Apr; 2(2):110-7. PubMed ID: 6461667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.
    Thompson RA; Winterborn MH
    Clin Exp Immunol; 1981 Oct; 46(1):110-9. PubMed ID: 6461451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy.
    Wyatt RJ; Julian BA; Rivas ML
    Am J Med Sci; 1991 Feb; 301(2):115-23. PubMed ID: 1826409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.
    Medof ME; Prince GM; Mold C
    Proc Natl Acad Sci U S A; 1982 Aug; 79(16):5047-51. PubMed ID: 6214790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    DiScipio RG
    Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor I deficiency and C3 nephritic factor: immunochemical findings and association with Neisseria meningitidis infection in two patients.
    Teisner B; Brandslund I; Folkersen J; Rasmussen JM; Poulsen LO; Svehag SE
    Scand J Immunol; 1984 Oct; 20(4):291-7. PubMed ID: 6239368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C; DiScipio RG; Kerr MA; Prohaska R
    Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I; Fujita T; Nussenzweig V
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.
    Miyazaki R; Kuroda M; Akiyama T; Otani I; Tofuku Y; Takeda R
    Clin Nephrol; 1984 Jun; 21(6):335-40. PubMed ID: 6205804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for glomerular modulation of complement activation.
    Moseley HL; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):9-13. PubMed ID: 95813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alternative complement pathway (author's transl)].
    Kazatchkine M; Nydegger U; Fearon DT
    Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum complement levels in infancy: age related changes.
    Davis CA; Vallota EH; Forristal J
    Pediatr Res; 1979 Sep; 13(9):1043-6. PubMed ID: 503656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic aspects of complement and glomerulonephritis.
    Praz F; Halbwachs L; Lesavre P
    Adv Nephrol Necker Hosp; 1984; 13():271-96. PubMed ID: 6089521
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
    Potter BJ; Brown DJ; Watson A; Jewell DP
    Gut; 1980 Dec; 21(12):1030-4. PubMed ID: 6450718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced alternative complement pathway control protein levels in anorexia nervosa: response to parenteral alimentation.
    Wyatt RJ; Farrell M; Berry PL; Forristal J; Maloney MJ; West CD
    Am J Clin Nutr; 1982 May; 35(5):973-80. PubMed ID: 6805290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of complement activation in membranous and membranoproliferative glomerulonephritis.
    Moseley HL; Whaley K
    Kidney Int; 1980 Apr; 17(4):535-44. PubMed ID: 6446614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.